Aslan Pharmaceuticals | 6-K:外國發行人報告(業績相關)
Aslan Pharmaceuticals | 6-K:外國發行人報告
Aslan Pharmaceuticals | 6-K:外國發行人報告
Aslan Pharmaceuticals | 6-K:外國發行人報告
Aslan Pharmaceuticals | 424B5:募資說明書
Aslan Pharmaceuticals | 6-K:外國發行人報告
Aslan Pharmaceuticals | S-8:員工福利計劃證券登記
Aslan Pharmaceuticals | 20-F:年度報告/過渡報告/註冊聲明
Aslan Pharmaceuticals | 6-K:外國發行人報告(業績相關)
Aslan Pharmaceuticals | EFFECT:其他
Aslan Pharmaceuticals | D:發行公告
Aslan Pharmaceuticals | CORRESP:信函
Aslan Pharmaceuticals | UPLOAD:其他
Aslan Pharmaceuticals | F-3:交易註冊聲明
Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Mitchell P. Kopin(4.4%),Daniel B. Asher(4.4%)等
Aslan Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Lind Global Fund II LP(5.7%),Lind Global Partners II LLC(5.7%)等
Aslan Pharmaceuticals | 424B5:募資說明書
Aslan Pharmaceuticals | 6-K:外國發行人報告(業績相關)
Aslan Pharmaceuticals | 6-K:外國發行人報告
Aslan Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-K2 HealthVentures Equity Trust LLC(5.2%),Parag Shah(5.2%)等
暫無數據